These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

877 related articles for article (PubMed ID: 32474093)

  • 21. Update on neurological manifestations of COVID-19.
    Yavarpour-Bali H; Ghasemi-Kasman M
    Life Sci; 2020 Sep; 257():118063. PubMed ID: 32652139
    [TBL] [Abstract][Full Text] [Related]  

  • 22. COVID-19: A Global Threat to the Nervous System.
    Koralnik IJ; Tyler KL
    Ann Neurol; 2020 Jul; 88(1):1-11. PubMed ID: 32506549
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Subjective neurological symptoms frequently occur in patients with SARS-CoV2 infection.
    Liguori C; Pierantozzi M; Spanetta M; Sarmati L; Cesta N; Iannetta M; Ora J; Mina GG; Puxeddu E; Balbi O; Pezzuto G; Magrini A; Rogliani P; Andreoni M; Mercuri NB
    Brain Behav Immun; 2020 Aug; 88():11-16. PubMed ID: 32416289
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Unpuzzling COVID-19: tissue-related signaling pathways associated with SARS-CoV-2 infection and transmission.
    Battagello DS; Dragunas G; Klein MO; Ayub ALP; Velloso FJ; Correa RG
    Clin Sci (Lond); 2020 Aug; 134(16):2137-2160. PubMed ID: 32820801
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neurological complications of coronavirus and COVID-19.
    Carod-Artal FJ
    Rev Neurol; 2020 May; 70(9):311-322. PubMed ID: 32329044
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Involvement of the Nervous System in SARS-CoV-2 Infection.
    Li H; Xue Q; Xu X
    Neurotox Res; 2020 Jun; 38(1):1-7. PubMed ID: 32399719
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The neurological manifestations of COVID-19: a review article.
    Niazkar HR; Zibaee B; Nasimi A; Bahri N
    Neurol Sci; 2020 Jul; 41(7):1667-1671. PubMed ID: 32483687
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Not Available].
    Traore A; Pot C; Bonvin C; Wicki B; Alvarez V
    Rev Med Suisse; 2020 May; 16(692):947-949. PubMed ID: 32374543
    [No Abstract]   [Full Text] [Related]  

  • 29. Neurological Manifestations of COVID-19: A systematic review and current update.
    Whittaker A; Anson M; Harky A
    Acta Neurol Scand; 2020 Jul; 142(1):14-22. PubMed ID: 32412088
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patients with COVID-19 and neurological manifestations show undetectable SARS-CoV-2 RNA levels in the cerebrospinal fluid.
    Espíndola OM; Siqueira M; Soares CN; Lima MASD; Leite ACCB; Araujo AQC; Brandão CO; Silva MTT
    Int J Infect Dis; 2020 Jul; 96():567-569. PubMed ID: 32505878
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19).
    Bourgonje AR; Abdulle AE; Timens W; Hillebrands JL; Navis GJ; Gordijn SJ; Bolling MC; Dijkstra G; Voors AA; Osterhaus AD; van der Voort PH; Mulder DJ; van Goor H
    J Pathol; 2020 Jul; 251(3):228-248. PubMed ID: 32418199
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neurological manifestations in coronavirus disease 2019.
    Corona T; Rodríguez-Violante M; Delgado-García G
    Gac Med Mex; 2020; 156(4):317-320. PubMed ID: 32831319
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neurologic manifestations in hospitalized patients with COVID-19: The ALBACOVID registry.
    Romero-Sánchez CM; Díaz-Maroto I; Fernández-Díaz E; Sánchez-Larsen Á; Layos-Romero A; García-García J; González E; Redondo-Peñas I; Perona-Moratalla AB; Del Valle-Pérez JA; Gracia-Gil J; Rojas-Bartolomé L; Feria-Vilar I; Monteagudo M; Palao M; Palazón-García E; Alcahut-Rodríguez C; Sopelana-Garay D; Moreno Y; Ahmad J; Segura T
    Neurology; 2020 Aug; 95(8):e1060-e1070. PubMed ID: 32482845
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neurological associations of COVID-19.
    Ellul MA; Benjamin L; Singh B; Lant S; Michael BD; Easton A; Kneen R; Defres S; Sejvar J; Solomon T
    Lancet Neurol; 2020 Sep; 19(9):767-783. PubMed ID: 32622375
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Does SARS-CoV-2 infection cause chronic neurological complications?
    Hascup ER; Hascup KN
    Geroscience; 2020 Aug; 42(4):1083-1087. PubMed ID: 32451846
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neurotropism of SARS-CoV 2: Mechanisms and manifestations.
    Conde Cardona G; Quintana Pájaro LD; Quintero Marzola ID; Ramos Villegas Y; Moscote Salazar LR
    J Neurol Sci; 2020 May; 412():116824. PubMed ID: 32299010
    [No Abstract]   [Full Text] [Related]  

  • 37. [COVID-19: neurological manifestations : What we know so far].
    Yilmaz U; Lepper PM; Reith W
    Radiologe; 2020 Oct; 60(10):916-918. PubMed ID: 32880004
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Spectrum of Neurological Manifestations in Covid-19: A Review.
    Garg RK
    Neurol India; 2020; 68(3):560-572. PubMed ID: 32643664
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neurological manifestations of COVID-19: a review of what we know so far.
    Gklinos P
    J Neurol; 2020 Sep; 267(9):2485-2489. PubMed ID: 32458197
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Report of a patient with neurological symptoms as the sole manifestation of SARS-CoV-2 infection.
    Escalada Pellitero S; Garriga Ferrer-Bergua L
    Neurologia (Engl Ed); 2020 May; 35(4):271-272. PubMed ID: 32364120
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 44.